机构：[1]Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China医技科室病理科首都医科大学宣武医院[2]State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, Jiangsu 210042, China[3]Department of Pathology, Liaocheng People’s Hospital, Liaocheng, Shandong 252000, China.
This work was supported by the Beijing Excellent Talents
Training Project, China (No. 201600026833ZK07) and
the Beijing Higher Education Young Elite Teacher Project,
China (No. CIT&TCD201904091).
第一作者机构：[1]Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
通讯作者：
通讯机构：[*1]Department of Pathology, Liaocheng People’s Hospital, 67# Dongchang West Road, Liaocheng, Shandong 100053, China
推荐引用方式(GB/T 7714)：
Wang Lei-Ming,Song Chao,Li Ying-Xue,et al.A novel isocitrate dehydrogenase 1 G131D mutation in glioblastoma.[J].CHINESE MEDICAL JOURNAL.2021,134(4):486-488.doi:10.1097/CM9.0000000000001172.
APA：
Wang Lei-Ming,Song Chao,Li Ying-Xue,Zhang Xue-Dong,Ji Yu-Hang&Wen Wen-Juan.(2021).A novel isocitrate dehydrogenase 1 G131D mutation in glioblastoma..CHINESE MEDICAL JOURNAL,134,(4)
MLA：
Wang Lei-Ming,et al."A novel isocitrate dehydrogenase 1 G131D mutation in glioblastoma.".CHINESE MEDICAL JOURNAL 134..4(2021):486-488
